Funtleyder Leslie D. has filed 24 insider transactions across 2 companies since November 2023.
Most recent transaction: a disposition of 2375000 shares of Applied Therapeutics, Inc. ($APLT) on February 03, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | D | Common Stock | 2375000 | $0.00 | 152,959.0000 | 145,559,604 | 93.95% | 1.63% |
| Dec. 19, 2025 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 1187500 | $0.00 | 2,527,959.0000 | 145,559,604 | 88.59% | 0.82% |
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 40502 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.03% |
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 150000 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.10% |
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 16500 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 10230 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | D | Stock Option (Right to Buy) | 20460 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.01% |
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | U | Common Stock | 152959 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.11% |
| Jan. 1, 2026 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 150000 | $0.00 | 1,340,459.0000 | 145,559,604 | 12.60% | 0.10% |
| Dec. 18, 2025 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Funtleyder Leslie D. | Director | A | Stock Option (right to buy) | 8200 | $0.00 | 8,200.0000 | 115,058,619 | 9999.99% | 0.01% |
| Oct. 1, 2025 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 150000 | $0.00 | 1,190,459.0000 | 145,559,604 | 14.42% | 0.10% |
| June 9, 2025 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 150000 | $0.00 | 787,121.0000 | 139,534,746 | 23.54% | 0.11% |
| July 1, 2025 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | A | Common Stock | 150000 | $0.00 | 937,121.0000 | 139,534,746 | 19.06% | 0.11% |
| March 24, 2025 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | See Remarks | A | Common Stock | 350000 | $0.00 | 740,459.0000 | 139,534,746 | 89.64% | 0.25% |
| March 4, 2025 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | See Remarks | S | Common Stock | 14502 | $0.44 | 390,459.0000 | 139,534,746 | 3.58% | 0.01% |
| Feb. 6, 2025 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | See Remarks | S | Common Stock | 22950 | $0.61 | 404,961.0000 | 139,534,746 | 5.36% | 0.02% |
| Dec. 19, 2024 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | See Remarks | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 144,345,781 | 9999.99% | 0.10% |
| Dec. 19, 2024 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | See Remarks | A | Common Stock | 150000 | $0.00 | 427,911.0000 | 144,345,781 | 53.97% | 0.10% |
| Dec. 10, 2024 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Funtleyder Leslie D. | Director | A | Stock Option (right to buy) | 8200 | $0.00 | 8,200.0000 | 0 | 9999.99% | 0.00% |
| Aug. 22, 2024 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | S | Common Stock | 13530 | $5.83 | 277,911.0000 | 84,244,494 | 4.64% | 0.02% |
| June 6, 2024 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | S | Common Stock | 16980 | $4.32 | 291,441.0000 | 84,244,494 | 5.51% | 0.02% |
| March 14, 2024 | Applied Therapeutics, Inc. | $APLT | Funtleyder Leslie D. | Chief Financial Officer | S | Common Stock | 28727 | $5.39 | 308,421.0000 | 84,244,494 | 8.52% | 0.03% |
| Nov. 13, 2023 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Funtleyder Leslie D. | Director | A | Stock Option (right to buy) | 8200 | $0.00 | 8,200.0000 | 0 | 9999.99% | 0.00% |